The researchers argue that their findings, published in Scientific Reports, could help clinicians anticipate which patients ...

Phase 2 data showed rapid increases in CD34+ stem cells, allowing same-day dosing and collection. ・Daratumumab-treated patients, who often struggle with mobilization, also achieved strong collection ...

Research presented December 8 at the American Society of Hematology Conference in Florida, has shown that a new kind of CAR T ...

We spoke with representatives from Anthony Nolan and eXmoor to discuss both their collaboration and the importance of ethical ...

Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced new ...

Adding motixafortide to standard stem cell mobilization therapy for autologous hematopoietic stem cell transplantation (ASCT) significantly improved collection success rates vs standard therapy plus a ...

Key Highlights Motixafortide effectively mobilized sufficient hematopoietic stem cells (HSCs) in patients with sickle cell disease enabling accelerated access to gene therapies 90% (9 of 10) of ...

This week’s episode of “The Top Line” is the second part of a three-part series exploring the latest advancements in cell and gene therapy manufacturing. In this episode, Fierce Pharma’s Fraiser ...

The world’s only cell therapy collection vehicle opened in San Antonio and recorded its first donation on Monday, Oct. 20, 2025. (BBG Advanced Therapies) SAN ANTONIO – The world’s only cell therapy ...

A live colony of human induced pluripotent stem cells fills the screen of a microscope. (Allen Institute Photo) Space: The final frontier … for stem cells? Seattle’s Allen Institute for Cell Science ...